Skip to main content

Bill and Melinda Gates back UK A.I. start-up developing antiviral drugs to prevent pandemics

Bill and Melinda Gates have backed a U.K. start-up called Exscientia that's trying to design new drugs with artificial intelligence software.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.